UV GERMI Societe Anonyme

As of December 31, 2024, UV GERMI Societe Anonyme carries a market capitalization of 8.65M, placing it among publicly traded companies globally. Its enterprise value stands at 3.98M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

UV GERMI Societe Anonyme's next confirmed earnings release is scheduled for April 23, 2027.

As of December 31, 2024, UV GERMI Societe Anonyme has 3.18M shares outstanding.

These figures are as of December 31, 2024.

As of December 31, 2024, UV GERMI Societe Anonyme maintains a current ratio of 8.10, meaning it holds 8.1x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2024.

As of the close on October 23, 2026, UV GERMI Societe Anonyme's stock has gained approximately 3.08% over the past 52 weeks. The 50-day moving average sits at 2.58, while the 200-day moving average is 2.57.

As of December 31, 2024, UV GERMI Societe Anonyme holds 4.76M in cash and equivalents against 91,992.00 in total debt, resulting in a net debt position of -4.16M. Total book value stands at 9.88M, with working capital of 8.06M providing operational flexibility.